Hospira Healthcare India Pvt. - July 1, 2016

$117.00
The list of observations noted below document that the Quality Unit has not performed the necessary assessments/reviews to ensure that the objectionable conditions do not negatively affect the aseptic manufacturing processes and Quality Control tests in support of the finished sterile drug products.